VistaGen Therapeutics (United States)
- Research works
- 30 ▲ 61% vs 2013–17
- Citations
- 2k 66.6 per fractional work
- Top-10% rate
- 4.7% record average 16.5%
- Open access
- 56% world 28%
Not ranked overall: VistaGen Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 9.4×. Every wedge is a field page.
Which keywords describe research at VistaGen Therapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Depression, Obesity, Clinical Trials, Schizophrenia, Pluripotent Stem Cells, Weight Loss, Transcriptional Regulation and Embryonic Stem Cells.
- Vasomotor Symptoms
- Property Rights
- Off-Label Drug Use
- Estrogen
- Biomedical Ontologies
- Neurobiology
- Inflammation
- Tryptophan Metabolism
- Immune Activation
- Microglia
- Cardiovascular Disease
- Embryonic Stem Cells
- Breast Cancer
- Transcriptional Regulation
- Deep Learning
- Oxidative Stress
- Obesity
- Depression
- Clinical Trials
- Schizophrenia
- Pluripotent Stem Cells
- Weight Loss
- Cognitive Function
- Induced Pluripotent Stem Cells
- Cytokines
- Neuroinflammation
- Stress
- Bone Mineral Density
- Menopause
- Neurological Disorders
- Eminent Domain
- Hormone Therapy
- Pediatric Pharmacokinetics
- Text Mining
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 34 words, with their numbers
- Depression4▲ 17×5 topics
- Obesity2▲ 10×5 topics
- Clinical Trials2▲ 10×5 topics
- Oxidative Stress2▲ 3.1×6 topics
- Schizophrenia2▲ 44×3 topics
- Deep Learning2▲ 2.5×4 topics
- Pluripotent Stem Cells2▲ 75×2 topics
- Transcriptional Regulation2▲ 20×2 topics
- Weight Loss2▲ 33×3 topics
- Breast Cancer1▲ 17×3 topics
- Cognitive Function1▲ 23×3 topics
- Embryonic Stem Cells1▲ 65×1 topic
- Induced Pluripotent Stem Cells1▲ 137×1 topic
- Cardiovascular Disease1▲ 4.0×4 topics
- Cytokines1▲ 16×2 topics
- Microglia1▲ 50×2 topics
- Neuroinflammation1▲ 16×3 topics
- Immune Activation1▲ 44×1 topic
- Stress1▲ 10×3 topics
- Tryptophan Metabolism1▲ 103×1 topic
- Bone Mineral Density1▲ 44×2 topics
- Inflammation1▲ 1.64×8 topics
- Menopause1▲ 80×2 topics
- Neurobiology1▲ 11×4 topics
- Neurological Disorders1▲ 5.3×4 topics
- Biomedical Ontologies1▲ 124×1 topic
- Eminent Domain1▲ 540×1 topic
- Estrogen1▲ 45×1 topic
- Hormone Therapy1▲ 32×2 topics
- Off-Label Drug Use1▲ 91×1 topic
- Pediatric Pharmacokinetics1▲ 91×1 topic
- Property Rights1▲ 29×1 topic
- Text Mining1▲ 39×1 topic
- Vasomotor Symptoms1▲ 177×1 topic
Which research topics does VistaGen Therapeutics (United States) publish most on?
By volume in 2022–2025: Menopause: Health Impacts and Treatments, Advanced Technologies in Various Fields, Recommender Systems and Techniques and Mobile Crowdsensing and Crowdsourcing.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Menopause: Health Impacts and Treatments Endocrinology, Diabetes and Metabolism 1 works
- 2 Advanced Technologies in Various Fields Artificial Intelligence 1 works
- 3 Recommender Systems and Techniques Information Systems 1 works
- 4 Mobile Crowdsensing and Crowdsourcing Computer Science Applications 1 works
- 5 Neuroscience and Neural Engineering Cellular and Molecular Neuroscience 0 works
- 6 Biochemical Analysis and Sensing Techniques Nutrition and Dietetics 0 works
- 7 Cardiac electrophysiology and arrhythmias Cardiology and Cardiovascular Medicine 0 works
- 8 Allergic Rhinitis and Sensitization Immunology and Allergy 0 works
- 9 Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes Experimental and Cognitive Psychology 0 works
- 10 Olfactory and Sensory Function Studies Sensory Systems 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has VistaGen Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 61% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in South San Francisco
- Sunesis (United States)
- Exelixis (United States)
- Kaiser Permanente South San Francisco Medical Center
- Cytokinetics (United States)
- Portola Pharmaceuticals (United States)
- NGM Biopharmaceuticals (United States)
- Rapt Therapeutics (United States)
- Atara Biotherapeutics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.